Medical/Pharmaceuticals

EDAN Announces 2020 Annual Results and 2025 Outlook: Revenues Increased 104.1%

SHENZHEN, China, March 16, 2021 /PRNewswire/ -- EDAN Instruments, Inc.  ("EDAN" or the "Company) (SHE: 300206) on Monday announced its results for the preceding fiscal year (FY 2020) with revenue of CNY 2.3 billion. The company also revealed its strategic 5+1 plan and its ...

2021-03-16 21:37 4606

The remarkable rise of Meenaxi Research Inc.

EDISON, N.J., March 16, 2021 /PRNewswire/ -- Mr. Kaushik Gandhi, the founder of Meenaxi Research Inc. is a pioneer in herbal and allopathic dermatological research. His start-up's unique formulation for atopic dermatitis, has etched an innovative pathway in the medical research industry. Mr. Gan...

2021-03-16 21:00 2626

U-Smell-It LLC Honored in Global $6M XPRIZE Rapid COVID Testing Competition

GUILFORD, Conn., March 16, 2021 /PRNewswire/ -- U-Smell-It™ LLC, a Guilford -based company specializing in innovative COVID detection techniques, has announced that it has won the$6M XPRIZE Rapid COVID Testing, a global effort to develop breakthrough COVID testing methods. XPRIZE Rapid COVID Test...

2021-03-16 21:00 1926

Apollo Hospitals, India becomes the first Asian Hospital to perform four consecutive MitraClip procedures in a day

CHENNAI, India, March 16, 2021 /PRNewswire/ -- The Apollo Hospitals group, one ofAsia's largest and most trusted healthcare group, notched up a record milestone with the successful completion of four consecutive MitraClip procedures in one day. The MitraClip implants were carried out on four pati...

2021-03-16 20:58 3386

Market of TCM Lianhua Qingwen Enlarged with Kenya's Approval

SHIJIAZHUANG, China, March 16, 2021 /PRNewswire/ -- In an announcement published by Yiling Pharmaceutical on Tuesday, it is disclosed the enterprise has received the herbal product license for Lianhua Qingwen Capsules from the Pharmacy and Poisons Board of the Ministry of Health ofKenya. Kenya i...

2021-03-16 20:20 2154

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19

SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccine Contract Development and Manufacturing Organization (CDMO), today announced it achieved the weather-tight construction milestone of its vaccine manufacturing facility currently under construction ...

2021-03-16 16:30 3541

Merck Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer

Not intended for US-, Canada- or UK-based media DARMSTADT, Germany, March 16, 2021 /PRNewswire/ -- Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of ...

2021-03-16 15:00 3207

Sihuan Pharmaceutical (0460.HK): 'A Friend of Time' 2021 - The Turning-point Year

HONG KONG, March 16, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal role in China's domestic medical industry and is a leading company for the development of the country's cardio-cerebral vascular prescription drugs. According to IMS data in 2018, Sihuan Pharmaceut...

2021-03-16 14:48 4542

QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines

Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...

2021-03-16 06:35 3098

CBC Group Announces the Appointment of Roger Perlmutter as Science Partner

SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce that Roger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman, Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Bo...

2021-03-15 22:00 3390

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 3615

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 3454

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 5423

Antengene Included in the Shenzhen-Hong Kong Stock Connect

SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...

2021-03-15 09:40 4937

Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea

SHANGHAI and SEOUL, South Korea, March 15, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolo...

2021-03-15 08:00 4127

Agiomix Receives the First ISO 15189 Accreditation for Next Generation Sequencing in the Region

DUBAI, UAE, March 15, 2021 /PRNewswire/ -- Agiomix has received the ISO 15189:2012 Accreditation from the Emirates International Accreditation Centre for Next Generation Sequencing clinical assays. Agiomix Labs, Dubai, ...

2021-03-15 07:50 2678

SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria

MELBOURNE, Australia, March 15, 2021 /PRNewswire/ -- SuperTrans Medical has announced the appointment of three Australian companies to play pivotal roles in an upcoming clinical drug trial that offers new hope in the plight against antimicrobial resistance (AMR), which the World Health Organisati...

2021-03-15 07:08 1977

Thinklabs Announces Medical Device Single Audit Program (MDSAP) Certification and TGA Approval in Australia

Thinklabs is opening business to Australian territories, inclusive of hospitals, private practices, and medical facilities. CANBERRA, Australia, March 9, 2021 /PRNewswire/ -- Thinklabs, manufacturer of Thinklabs One, the smallest, most powerful electronic stethoscope in the world, today ann...

2021-03-12 23:06 4887

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately$1 billion, which includes buyer's assumption of certain liabilities and seller's retention o...

2021-03-12 22:00 9033

Harbour BioMed Announces Dosing of First Patient in Tanfanercept Phase III Clinical Trial

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI and SUZHOU, China, March 12, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142) today announced the dosing of the first patient in the Phase III clinical trial of its new global investigational tumor necrosis factor (TNF) receptor-1 f...

2021-03-12 09:00 6598
1 ... 618619620621622623624 ... 644